Orion Pharma Ltd. introduces 'Rovex' to achieve the target therapeutic goal successfully in hyperlipidemia

'Successfully achieves the target therapeutic goal'-bearing this slogan Orion Pharma Ltd. has launched a new product 'Rovex', at its Corporate Head Quarter, Orion House on 23rd February 2016. 'Rovex' is the Brand of Rosuvastatin available in two different strengths as 5mg & 10mg tablet. Rosuvastatin is the 3rd generation statin which achieves the target therapeutic goal successfully.

A number of renowned and experienced physicians from reputed institutions at Dhaka were present on the occasion. Physicians present at the program shared their views about the modern management of hyperlipidemia. The launching program was headed by Mrs. Arzuda Karim, Director of Orion Pharma Ltd. with Managing Director of Orion Group Mr. Salman Obaidul Karim.

'Rovex' & also expressed thanks to all participants for their presence and make the event successful.  He also mentioned that all the sister concerns of Orion Group were contributing to the nation.

Back to Csr List